Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Philippine Heart Association, Dr. HB Calleja Heart and Vascular Institute, St. Luke's Medical Center, Metro Manila, Philippines.
J Clin Hypertens (Greenwich). 2021 Jan;23(1):3-11. doi: 10.1111/jch.14074. Epub 2020 Oct 11.
Hypertension is one of the most powerful modifiable risk factors for cardiovascular disease. It is usually asymptomatic and therefore essential to measure blood pressure regularly for the detection of hypertension. Home blood pressure monitoring (HBPM) is recognized as a valuable tool to monitor blood pressure and facilitate effective diagnosis of hypertension. It is useful to identify the masked or white-coat hypertension. There is also increasing evidence that supports the role of HBPM in guiding antihypertensive treatment, and improving treatment compliance and hypertension control. In addition, HBPM has also shown prognostic value in predicting cardiovascular events. Despite these benefits, the use of HBPM in many parts of Asia has been reported to be low. An expert panel comprising 12 leading experts from 10 Asian countries/regions convened to share their perspectives on the realities of HBPM. This article provides an expert summary of the current status of HBPM and the key factors hindering its use. It also describes HBPM-related initiatives in the respective countries/regions and presents strategies that could be implemented to better support the use of HBPM in the management of hypertension.
高血压是心血管疾病最强有力的可调节危险因素之一。它通常没有症状,因此定期测量血压对于发现高血压至关重要。家庭血压监测(HBPM)被认为是监测血压和有效诊断高血压的有价值的工具。它有助于识别隐匿性或白大衣性高血压。越来越多的证据也支持 HBPM 在指导降压治疗、提高治疗依从性和控制高血压方面的作用。此外,HBPM 在预测心血管事件方面也具有预后价值。尽管有这些益处,但据报道,亚洲许多地区的 HBPM 使用情况较低。一个由来自 10 个亚洲国家/地区的 12 位领先专家组成的专家小组召开会议,分享他们对 HBPM 实际情况的看法。本文提供了对当前 HBPM 现状和阻碍其使用的关键因素的专家总结。它还描述了各国家/地区与 HBPM 相关的举措,并提出了可以实施的策略,以更好地支持在高血压管理中使用 HBPM。